Danaher (DHR) Stock News
$DHR · NYSE · 2 stories in 30 daysBORSA has published 2 stories on Danaher (DHR) in the past 30 days. BORSA’s news read on DHR is bullish at 60/100, unchanged over 24 hours, based on 1 company event over the past 7 days. DHR last closed at $222.84 on Oct 13, up 3.35% over five sessions and up 9.84% over the past month. Danaher’s next earnings report is scheduled for Wednesday, Oct 21 before the open.
The wire on $DHR
newest first · updated · direct subject stories onlyMorgan Stanley increased its price target for Danaher shares to $240.00.
bullish 65 · impact 30Danaher announced plans to launch its first AI-powered autonomous lab in early 2027. The lab aims to deliver up to 8x faster discovery of affinity reagents and a tenfold increase in annual reagent generation. It combines AI, robotics, and technologies from Beckman Coulter Life Sciences, Cytiva, Genedata, Integrated DNA Technologies, and Molecular Devices.
· impact 40